Dr Laura Gamble
Professor Fiona Matthews
Comorbid health conditions and their impact on social isolation, loneliness, quality of life, and well-being in people with dementia: longitudinal findings from the IDEAL programme2024 Dr Laura Gamble
Professor Fiona Matthews
Living well with dementia: An exploratory matched analysis of minority ethnic and white people with dementia and carers participating in the IDEAL programme2024 Dr Laura Gamble
Professor Fiona Matthews
Are profiles of social, cultural, and economic capital related to living well with dementia? Longitudinal findings from the IDEAL programme2023 Dr Laura Gamble
Dyadic influences on awareness of condition in people with dementia: findings from the IDEAL cohort2023 Dr Laura Gamble
Evaluating ‘living well’ with mild-to-moderate dementia: Co-production and validation of the IDEAL My Life Questionnaire2023 Dr Laura Gamble
Professor Fiona Matthews
Longitudinal Predictors of Informant-Rated Involvement of People with Dementia in Everyday Decision-Making: Findings from the IDEAL Program2023 Dr Laura Gamble
Professor Fiona Matthews
Profiles of social, cultural, and economic capital as longitudinal predictors of stress, positive experiences of caring, and depression among spousal carers of people with dementia2023 Dr Laura Gamble
Resilience in caregivers of people with mild-to-moderate dementia: findings from the IDEAL cohort2023 Dr Laura Gamble
The associations between personality traits and quality of life, satisfaction with life, and well-being over time in people with dementia and their caregivers: findings from the IDEAL programme2023 Dr Laura Gamble
Professor Fiona Matthews
"Living Well" Trajectories Among Family Caregivers of People With Mild-to-Moderate Dementia in the IDEAL Cohort2022 Dr Laura Gamble
Dr Holly Bennett
Professor Fiona Matthews
A comparison of well-being of carers of people with dementia and their ability to manage before and during the COVID-19 pandemic: findings from the IDEAL study2022 Dr Laura Gamble
Professor Fiona Matthews
Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study2022 Dr Laura Gamble
Dr Louise Allan
Professor Fiona Matthews
Impact of COVID-19 on ‘Living Well’ with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort2022 Dr Laura Gamble
Professor Fiona Matthews
Longitudinal Trajectories of Quality of Life Among People With Mild-to-Moderate Dementia: A Latent Growth Model Approach With IDEAL Cohort Study Data2022 Dr Holly Bennett
Dr Laura Gamble
Professor Fiona Matthews
Minimal Impact of COVID-19 Pandemic on the Mental Health and Wellbeing of People Living With Dementia: Analysis of Matched Longitudinal Data From the IDEAL Study2022 Dr Laura Gamble
Professor Fiona Matthews
Predictors of Awareness of Functional Ability in People with Dementia: The Contribution of Personality, Cognition, and Neuropsychiatric Symptoms – Findings from the IDEAL Program2022 Dr Laura Gamble
Professor Fiona Matthews
Psychological Processes in Adapting to Dementia: Illness Representations Among the IDEAL Cohort2022 Dr Laura Gamble
Dr Yu-Tzu Wu
Professor Fiona Matthews
The Use and Costs of Paid and Unpaid Care for People with dementia: Longitudinal Findings from the IDEAL cohort2022 Dr Laura Gamble
Trajectories of socio-emotional functioning in early-stage dementia: implications for the individual with dementia and their family carer2021Dr Laura Gamble
Professor Fiona Matthews
Living Alone with Mild-To-Moderate Dementia: Findings from the IDEAL Cohort2020 Dr Laura Gamble
Targeting Metabolic Activity in High-Risk Neuroblastoma Through Monocarboxylate Transporter 1 (MCT1) Inhibition2020Dr Laura Gamble
Inhibition of Polyamine Synthesis and Uptake Reduces Tumor Progression and Prolongs Survival in Mouse Models of Neuroblastoma2019Livingstone Fultang
Dr Laura Gamble
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma2019Dr Laura Gamble
Suppression of the ATP-binding Cassette Transporter ABCC4 Impairs Neuroblastoma Tumour Growth and Sensitises to Irinotecan in Vivo2017Dr Laura Gamble
MYCN Promotes Neuroblastoma Malignancy by Establishing a Regulatory Circuit With Transcription Factor AP42016 Dr Laura Gamble
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression2016Dr Laura Gamble
Therapeutic Targeting of the MYC Signal by Inhibition of Histone Chaperone FACT in Neuroblastoma2015Dr Jane Carr-Wilkinson
Bojidar Goranov
Dr Chris Redfern
Dr Laura Gamble
Professor John Lunec
et al.Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression2011Dr Lindi Chen
Dr Laura Gamble
Professor John Lunec
Professor Deborah Tweddle
p53 is a direct transcriptional target of MYCN in neuroblastoma2010